Company Filing History:
Years Active: 2009-2011
Title: Celebrating the Innovations of Bruce Jacobson
Introduction
Bruce Jacobson, an accomplished inventor based in Framingham, MA, has made significant contributions to the field of biotechnology. With two patents to his name, Jacobson is recognized for his innovative work that revolves around immunology and therapeutic agents. His contributions aim to enhance the understanding and treatment of diseases related to the interleukin-13 (IL-13) pathway.
Latest Patents
Jacobson's latest patents focus on nucleic acids encoding IL-13 binding agents. These agents, including antibodies and their fragments, specifically bind to IL-13. The technology aims to modulate the interaction of IL-13 with its receptors and signaling mediators, presenting potential breakthroughs in therapeutic applications for various inflammatory and allergic conditions.
Career Highlights
Currently, Bruce Jacobson is associated with Wyeth, a leading biopharmaceutical company known for its innovative research and product development. His work there supports the advancement of treatments that can significantly impact healthcare, especially concerning immune response modulation.
Collaborations
Jacobson collaborates with talented professionals in the field, including Lioudmila Tchistiakova and Marion T Kasaian. These collaborations enhance his research initiatives and expand the scope of innovations derived from his work, further solidifying the impact of his inventions on medical science.
Conclusion
As an inventor, Bruce Jacobson continues to push the boundaries of innovation in biotechnology. His patents on IL-13 binding agents reflect a commitment to advancing therapeutic solutions and underscore the importance of collaboration in the field of research and development. Jacobson’s contributions exemplify the vital role inventors play in shaping the future of medicine.